Literature DB >> 28889785

Validation of Fetal Medicine Foundation algorithm for prediction of pre-eclampsia in the first trimester in an unselected Brazilian population.

Guilherme Antonio Rago Lobo1, Paulo Martin Nowak1, Ana Paula Panigassi1, Angélia Iara Felipe Lima1, Edward Araujo Júnior1, Luciano Marcondes Machado Nardozza1, David Baptista Silva Pares1.   

Abstract

OBJECTIVE: The objective of this study is to evaluate the predictive performance of the Fetal Medicine Foundation (FMF) algorithm for prediction of preeclampsia (PE) between 11 and 14 weeks of gestation in an unselected Brazilian population.
METHODS: We conducted a prospective cohort study with 617 singleton pregnancies of unselected risk. Biophysical markers (mean pulsatility index, mean arterial pressure) and biochemical markers (placental growth factor (PLGF) and PAPP-A) were inserted into the FMF software and converted into multiples of the median (MoM). The subjects were divided into five groups: early-onset PE, parturition <34 weeks' gestation; preterm PE, parturition <37 weeks; PE, parturition at any gestational age; gestational hypertension (GH); and control group. Areas under the receiver operating characteristics curve (AUC) were calculated for the outcomes.
RESULTS: Among 617 patients, seven developed early-onset PE, 18 developed preterm PE (seven early PE plus 11 delivered between 34 and 36 + 6 weeks gestation), 34 developed PE (18 preterm PE plus 16 delivered after 37-week gestation), 12 pregnant women developed GH, and 517 women comprised the control group. The best predictive performance using the FMF algorithm occurred in the early-onset PE group, with AUC = 0.946 (95% CI 0.919-0.973) and the detection rate of 28.6% and 85.7% for 5% and 10% false-positive (FP), respectively.
CONCLUSIONS: The FMF algorithm to predict PE was effective in a Brazilian population, mainly in the early-onset form of the disease at 10% FP.

Entities:  

Keywords:  Brazilian population; fetal medicine foundation; first trimester; prediction; preeclampsia

Mesh:

Year:  2017        PMID: 28889785     DOI: 10.1080/14767058.2017.1378332

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  5 in total

1.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

2.  Systematic review of prediction models for gestational hypertension and preeclampsia.

Authors:  Edward Antwi; Mary Amoakoh-Coleman; Dorice L Vieira; Shreya Madhavaram; Kwadwo A Koram; Diederick E Grobbee; Irene A Agyepong; Kerstin Klipstein-Grobusch
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

3.  Clinical risk assessment in early pregnancy for preeclampsia in nulliparous women: A population based cohort study.

Authors:  Anna Sandström; Jonathan M Snowden; Jonas Höijer; Matteo Bottai; Anna-Karin Wikström
Journal:  PLoS One       Date:  2019-11-27       Impact factor: 3.240

4.  Performance of Fetal Medicine Foundation algorithm for first trimester preeclampsia screening in an indigenous south Asian population.

Authors:  Smriti Prasad; Daljit Singh Sahota; P Vanamail; Akshatha Sharma; Saloni Arora; Anita Kaul
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-04       Impact factor: 3.007

Review 5.  Non-Coding RNAs and Prediction of Preeclampsia in the First Trimester of Pregnancy.

Authors:  Manabu Ogoyama; Hironori Takahashi; Hirotada Suzuki; Akihide Ohkuchi; Hiroyuki Fujiwara; Toshihiro Takizawa
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.